The net result: the US government will no longer require shell companies to disclose their owners and beneficiaries, allowing wealthy corporations and individuals to hide their profits from the public ...
Maintenance immunotherapy after autologous bone marrow transplantation (ABMT) in relapsed follicular (R-FL) and mantle cell (R-MC) lymphomas (NHL). A monoinstitutional experience No significant ...
Matt Stankiewicz, Partner at The Volkov Law Group, joins us to take a deep dive into the FinCEN and OFAC enforcement actions. Matt outlines the facts underlying the enforcement actions and provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results